Health Affairs, 27, no. 1 (2008): 89-102 doi: 10.1377/hlthaff.27.1.89 © 2008 by Project HOPE	New Online   Pay Cuts For Medicare Docs   Access To Care Woes   Public Coverage More Efficient   Empowering Consumers

This Article Figures Only Full Text (HTML) Reprint (PDF) Submit a response to this article Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services E-mail this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to My Personal Archive Download to Citation Manager Reprints & Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Hirth, R. A. Articles by Piette, J. D. Search for Related Content PubMed PubMed Citation Articles by Hirth, R. A. Articles by Piette, J. D. Related Collections Access To Care Business Of Health Chronic Care Consumer Issues Insurance Coverage International Issues Pharmaceuticals Health Spending

Benefit Design

Out-Of-Pocket Spending And Medication Adherence Among Dialysis Patients In Twelve Countries

Few studies have examined drug costs and adherence in similar patient cohorts across countries. Using representative samples of hemodialysis patients from twelve countries, we examined out-of-pocket medication spending and cost-related nonadherence. Mean monthly spending ranged from $8 in the United Kingdom to $114 in the United States. The proportion of patients reporting nonadherence because of cost ranged from 3 percent in Japan to 29 percent in the United States. Out-of-pocket spending was related to national pharmaceutical financing policies and predicted national nonadherence rates. However, inconsistencies in the relationship between patient costs and nonadherence suggested that other social or policy factors also matter.

                      What's this?